Genomic Medicine XVI: Host Genomics and Infectious Disease
Event Details
On December 12-13, 2024, the National Human Genome Research Institute (NHGRI) and the National Institute of Allergy and Infectious Diseases (NIAID) will co-sponsor the 16th Genomic Medicine meeting, Host Genomics and Infectious Disease: Opportunities for Implementing Genomic Medicine, in Bethesda MD.
The meeting aims to identify needs, opportunities, and challenges for applying a patient’s genomic information (genome sequence, transcriptomic, epigenomic, etc. data) in the diagnosis, prevention, and treatment of infectious diseases. Persistent barriers and evidence gaps will be examined as opportunities for additional research.
Housing Form (deadline Nov 20)
Browse Agenda by Day: December 12 | December 13
All times are in ET.
Hybrid: Zoom Webinar (Requires Registration) and In-Person
The Bethesdan Hotel
Webcast Viewing Platforms
December 12
8:30 a.m. - Breakfast
9:00 a.m. - Welcome and Introductions
Goals of Genomic Medicine XVI
9:00 - 9:10
Eric Green
Jeanne Marrazzo
Structure, Goals, and Products of Prior NHGRI Genomic Medicine Meetings
9:10 - 9:15
Teri Manolio
9:15 a.m. - Session 1: Laying the Groundwork
Moderators: Eric Green, Jeanne Marrazzo
Keynote 1: Inherited Disorders of Immunity
9:15 - 9:35 a.m.
Jennifer Puck, UCSF
Keynote 2: Variant Pathogenicity in Rare Diseases within the ACMG and ClinGen Framework
9:35 - 9:55 a.m.
Ivan Chinn, Baylor
Discussion
9:55 - 10:45 a.m.
10:45 a.m. - Break
11:05 a.m. - Session 2: “Pathogen-First,” “Phenotype-First,” and “Sequence-First” Approaches to Genomic Medicine Implementation in Infectious Diseases
Moderators: Jonathan Berg, Lucas Buyon
Rare Infections - Disease Penetrance and Host Genetic Architecture
11:05 - 11:20 a.m.
Dusan Bogunovic, Columbia
Primary Immune Disorders and Specialized Infectious Testing
11:20 - 11:35 a.m.
Scott Canna, CHOP
NICU/PICU Sequencing and Variants Predisposing to Sepsis
11:35 - 11:50 a.m.
Stephen Kingsmore, Rady
Discussion
11:50 a.m. - 12:35 p.m.
12:35 p.m. - Lunch
1:20 p.m. - Session 3: Viral infections and Host Genomics
Moderators: Gail Jarvik, Casey Overby Taylor
Tales From the Genomes: Inherited Disorders of Immunity and Human Papillomaviruses Oncogenesis
1:20 - 1:35 p.m.
Andrea Lisco, NIAID
CCR5 and Host Response to West Nile and Other Flavivirus Infections
1:35 - 1:50 p.m.
Jean Lim, Mount Sinai
Understanding Viral Infection Through Host Genetics: Chronic Hepatitis B and C
1:50 - 2:05 p.m.
Priya Duggal, Johns Hopkins
IFNAR1, Viruses, and Pacific Public Health
2:05 - 2:20 p.m.
Ryan Minster, University of Pittsburgh
Discussion
2:20 - 3:05 p.m.
3:05 p.m. - Break
3:25 p.m. - Session 4: Current Status of Clinical Use of Host Genomic Information
Moderators: George Mensah, Inka Sastalla
The Evolving Landscape of Diagnostic Immunology: Past, Present, and Future
3:25 - 3:40 p.m.
Roshini Abraham, Ohio State
Available Technologies for Assessing Host Response
3:40 - 3:55 p.m.
Ephraim Tsalik, Danaher and Duke
Translating Host Response-Based Diagnostics to Clinical Practice
3:55 - 4:10 p.m.
Purvesh Khatri, Inflammatix and Stanford
Bridging the Gap: Addressing Obstacles in Genetic Counseling for Immune Disorders
4:10 - 4:25 p.m.
Morgan Similuk, NIAID
Discussion
4:25 - 5:10 p.m.
5:10 p.m. - Adjourn Day 1
December 13
8:00 a.m. - Breakfast
8:30 a.m. - Welcome
8:40 a.m. - Session 5: Pharmacogenetics (PGx) and Infectious Disease Management
Moderators: Carol Bult, Dan Roden
Aminoglycosides, Clinical Settings and PGx Variants Mediate Drug-Induced Hearing Loss
8:40 - 8:55 a.m.
Peter Steyger, Creighton
From Theory to Practice: Navigating Strategies and Barriers in the Clinical Implementation of Voriconazole Pharmacogenetics
8:55 - 9:10 a.m.
Aniwaa Owusu Obeng, Mount Sinai
Unique Challenges with Implementing G6PD Genetic Testing to Prevent Drug-Induced Hemolytic Anemia
9:10 - 9:25 a.m.
Roseann Donnelly, Massachusetts College of Pharmacy and Health Sciences
Pharmacogenetics of Antiviral Agents
9:25 - 9:40 a.m.
David Haas, VUMC
Discussion
9:40 - 10:25 a.m.
10:25 a.m. - Break
10:45 a.m. - Session 6: Implementation of Host Genomics in Clinical Care of Infectious Diseases
Moderators: Gillian Hooker, Erin Ramos
From Data to Diagnosis: The Clinical Implementation of Genomic Insights
10:45 - 11:00 a.m.
Magdalena Walkiewicz, NIAID
Germline vs. Somatic Variants and Other Considerations in Clinical NGS Testing
11:00 - 11:15 a.m.
Katherine Calvo, NIH
Incorporating Pathogen Genomic Data Into the Electronic Health Record
11:15 - 11:30 a.m.
Matthew Robinson, Johns Hopkins
What Motivates Clinicians To Use Molecular Diagnostics and What Obstacles Are Encountered That Deter Them? A Personal View
11:30 - 11:45 a.m.
Bob Nussbaum, UCSF
Discussion
11:45 a.m. - 12:30 p.m.
12:30.m. - Break to grab lunches
1:00 p.m. - Research Directions for 3 Themes - Summary of Discussions
Moderators: Rex Chisholm, Steve Holland
Host Genomic Testing for Diagnosis and Management
1:00 - 1:15 p.m.
Dusan Bogunovich, Columbia
A Path to Sustainability: Policy Development & Reimbursement Strategies
1:15 - 1:30 p.m.
Gillian Hooker, Concert Genetics
Technology Development and Application
1:30 - 1:45 p.m.
Marc Williams, Geisinger
Discussion
1:45 - 2:00 p.m.
2:00 p.m. - Summary and Next Steps
Geoff Ginsburg, Steve Holland, Teri Manolio
2:30 p.m. - Adjourn Day 2
Last updated: November 12, 2024